Company Filing History:
Years Active: 2019
Title: Linda M Gustavson: Innovator in Antibody Therapeutics
Introduction
Linda M Gustavson is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods for inflammatory bowel disease (IBD). Her innovative approach focuses on the use of antibody polypeptides that antagonize CD40.
Latest Patents
Linda holds a patent for a method of using antibody polypeptides that specifically bind to a novel epitope of human CD40 to treat IBD. This method provides a novel approach to treating inflammatory bowel disease by administering antibody polypeptides that do not exhibit CD40 agonist activity. The antibody polypeptides may consist of fusions of a domain antibody (dAb) comprising a single Vor Vdomain and an Fc domain. She has 1 patent to her name.
Career Highlights
Linda is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research in antibody therapeutics. Her work has been instrumental in developing new treatment options for patients suffering from IBD.
Collaborations
Linda collaborates with esteemed colleagues such as Marek Honczarenko and Vaishali Shah, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Linda M Gustavson is a trailblazer in the field of antibody therapeutics, with her innovative methods paving the way for new treatments for inflammatory bowel disease. Her contributions to biotechnology are noteworthy and continue to impact the medical community positively.